NCT01613716View on ClinicalTrials.gov

Ozurdex for Diabetic Macular Edema Treated With Pars Plana vitrEctomy and Membrane RemovAl (OPERA Study)

PHASE4CompletedINTERVENTIONAL

Enrollment

30

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

December 31, 2016

Study Completion Date

February 28, 2017

Conditions

Diabetic Macular EdemaEpiretinal Membrane

Interventions

DRUG

Ozurdex

Ozurdex .7 mg injected into the treated eye

Trial Locations (1)

44195

Cole Eye Institute, Cleveland Clinic, Cleveland

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Allergan

INDUSTRY

lead

The Cleveland Clinic

OTHER